Albemarle Corporation (ALB) Stock Forecast

NYSE: ALBAnalyst ratings, price target and estimates.

ALB analyst forecast

as of October 18, 2026
Analyst consensus
Buy
4.09 / 5 from 23 analysts
Price target
$161.78
average of analyst targets
Upside to target
+69.4%
from the latest close
Next earnings
November 4, 2026
EPS estimate $2.44
52-week range
$88.45 – $215.62

ALB analyst ratings

23 analysts
Strong buy
1148%
Buy
313%
Hold
939%
Sell
00%
Strong sell
00%

Number of analysts at each rating.

ALB price target

Price $95.48Target $161.78
52-week low $88.4552-week high $215.62

The average of analyst 12-month price targets compared with the latest close and the 52-week range.

ALB earnings per share estimates

Albemarle Corporation EPS estimates
PeriodAverageLowHighYear agoGrowthAnalysts
Current quarter (Sep '26)$2.58$1.81$3.40−$0.19+1,456.9%16
Current fiscal year (2026)$11.47$9.59$13.22−$0.79+1,551.9%20
Next fiscal year (2027)$11.26$6.14$15.94$11.47−1.8%19

Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.

ALB revenue estimates

Albemarle Corporation revenue estimates
PeriodAverageLowHighGrowthAnalysts
Current quarter (Sep '26)$1.54B$1.39B$1.66B+17.8%11
Current fiscal year (2026)$6.12B$5.79B$6.39B+19.0%17
Next fiscal year (2027)$6.28B$5.17B$8.15B+2.5%18

ALB EPS: reported and forecast

Reported EPSEstimate (average; low–high)

Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.

ALB revenue: reported and forecast

Reported revenueEstimate (average; low–high)

ALB EPS estimate revisions

Albemarle Corporation EPS estimate revisions
Period90 days ago60 days ago30 days ago7 days agoNowChange (90 d)Revisions (30 d)
Current quarter (Sep '26)$3.54$2.46$2.56$2.59$2.58−27.2%1 up · 2 down
Current fiscal year (2026)$12.57$11.52$11.56$11.49$11.47−8.8%1 up · 2 down
Next fiscal year (2027)$13.01$11.52$11.30$11.14$11.26−13.4%1 up · 3 down

How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.

ALB earnings surprises

Reported EPSEstimate

Reported EPS vs the consensus estimate for the last 12 quarters; ALB beat in 7 of 12.

What analysts expect from ALB

23 analysts cover Albemarle; their consensus rating is buy (4.09 on a 1–5 scale, where 5 is a strong buy). The average price target is $161.78, 69.4% above the latest close of $95.48. Analysts expect earnings of $11.47 per share for 2026, +1,551.9% from a year earlier. For 2027 the average estimate is $11.26 per share on revenue of $6.3 billion. Albemarle beat the EPS estimate in 7 of the last 12 quarters.

Related: ALB income statement, ALB key metrics, ALB chart. See the ALB stock overview for the latest quote and news.

ALB forecast FAQ

What is Albemarle's price target?

The average analyst price target for Albemarle is $161.78, 69.4% above the latest close of $95.48.

Is Albemarle a buy, hold or sell?

Of 23 analysts covering Albemarle, 11 rate it a strong buy, 3 a buy, 9 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.

What is Albemarle's EPS forecast?

Analysts forecast $11.47 per share for 2026 (range $9.59 to $13.22); for 2027 the estimate is $11.26.

What is Albemarle's revenue forecast?

The average revenue estimate for 2026 is $6.1 billion, growth of 19.0%; for 2027 it is $6.3 billion.

When does Albemarle report earnings?

Albemarle is expected to report results for the quarter ending September 30, 2026 on November 4, 2026 after the market closes; the EPS estimate is $2.44.

Does Albemarle usually beat earnings estimates?

Albemarle reported EPS at or above the analyst estimate in 7 of the last 12 quarters.

Specialty Chemicals: forecast